Studies demonstrate the efficacy of astragaloside IV in modulating macrophage polarization, reducing inflammation, and restoring homeostasis in conditions such as inflammatory bowel disease (IBD) through mechanisms related to STAT signaling, among others. Here, SOAT1 is linked to inflammatory bowel disease.